Needle-free diabetes care: 7 devices that painlessly monitor blood …
WEBOct 7, 2022 · D-Base is a shoebox-sized blood sugar monitor developed by the German firm DiaMonTech. The device measures blood sugar levels by beaming an infrared laser through the skin of a finger and causing glucose in the skin to convert the light to heat. The machine then calculates glucose levels based on the increase of heat in the skin.
10 neuroscience biotech companies you should know about
WEBAug 15, 2024 · Developing treatments for neurological diseases presents a huge challenge for neuroscience companies within the biotech industry. The central nervous system (CNS) is extremely complex and many neurological diseases can be difficult to treat due to the limited regenerative capacity of the CNS, and the fact that the blood-brain barrier – a specialized system of cells that blocks harmful ...
The twelve hottest biotech companies in the Boston area
WEBMar 12, 2024 · The Boston region has sprouted many influential public biotech companies. One of the most successful in recent years was Moderna, a giant messenger RNA (mRNA) specialist incubated by the VC firm Flagship Pioneering. Moderna would go on to produce one of the first COVID-19 vaccines in 2020. Another prestigious name, Vertex Pharmaceuticals, one ...
What trends will shape the biotech industry in 2024?
WEBJan 25, 2024 · Experts in the field believe that the biotech industry is poised for recovery in 2024, and one reason for that would be a favorable climate for M&A activity. A PwC report predicts the M&A deal totals could range from $225 billion to $275 billion. M&A will be among the trends that will influence the biotech market in 2024.
Labiotech.eu - Europe's leading Biotech News Website
WEB2 days ago · Europe’s rising biotech stars: 10 startups to watch in 2024. The European biotech industry is bustling with activity this year. Here’s a list of 10 European biotech companies likely to make a big splash. Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors.
Five AI drug discovery companies you should know about
WEBJan 5, 2024 · In November 2023, Cradle raised $24 million in series A financing led by Index Ventures with participation from Kindred Capital. This funding round took the total raised by the AI drug discovery company to date to $33 million. Exscientia . Considered a pioneer in the field of AI within the biopharma industry, Exscientia is an AI-driven precision medicine company committed to discovering ...
18 biotech companies in Switzerland to keep an eye on in 2024
WEBJul 2, 2024 · ALE.C04 is the Swiss biotech’s lead candidate in oncology. This monoclonal antibody targets CLDN1+ tumors and is currently in a phase 1/2 clinical trial for head and neck squamous cell carcinoma (HNSCC). It is being tested both as a monotherapy and in combination with pembrolizumab, an anti-PD-1 antibody.
ALS: how close are we to a cure? - Labiotech.eu
WEBMar 4, 2024 · Zilucoplan, a drug developed by Belgian biopharma UCB, is designed to prevent inflammation and tissue damage in people with ALS. This is done by inhibiting the target protein complement component 5. Previously, zilucoplan has shown efficacy in a phase 2 trial for myasthenia gravis, a disease that …
Is an HIV Cure Possible? The Future of HIV Therapy - Labiotech.eu
WEBDec 1, 2022 · HIV research has come a long way since the virus was discovered in the 1980s. Antiretroviral therapy was a major milestone that has changed the lives of millions; the goal now is to find an HIV cure. Back in 2008, Timothy Ray Brown was the first person to be cured of HIV. Known as the “Berlin patient”, Brown received two bone marrow ...
Humble Beginnings: The History of Modern Biotechnology
WEBDec 23, 2020 · The history of modern biotechnology began around four decades ago with the invention of genetic engineering. Genentech, one of the fundamental companies in this field, set many trends for modern biotech companies today. Biotechnology doesn’t necessarily involve labs. In fact, humans have been …